Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Hypocalcemia

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Hypocalcemia

Abhinav Goyal et al.
Free Books & Documents

Excerpt

Calcium homeostasis in the body is a complex interplay between different hormones, regulatory proteins, receptors, and serum chemistries. The main factors that regulate calcium homeostasis in the body are parathyroid hormone (PTH), 1,25(OH)-vitamin D (activated vitamin D or calcitriol), fibroblast growth factor 23 (FGF23), calcitonin, calcium-sensing receptor (CaSR), serum calcium, and serum phosphorus.

Serum calcium concentration is maintained within a very narrow range. Approximately 45% of the body's calcium is bound to plasma proteins, primarily albumin. Approximately 15% is bound to small anions such as phosphate and citrate. And approximately 40% is in the free or ionized state, which is the active state. Most laboratories report total serum calcium concentration, which ranges between 8.5 to 10.5 mg/dL (2.12 to 2.62 mmol/L). Ionized calcium can also be measured, and the normal range is 4.65 to 5.25 mg/dL (1.16 to 1.31 mmol/L). Numbers below this range are considered to be hypocalcemic. Because the majority of body calcium is bound to albumin, total calcium should always be corrected for albumin level before the diagnosis of hypocalcemia is made. There is an approximately 0.8 mg/dL (0.25 mmol/L) drop in serum total calcium concentration for every 1 g/dL (10 g/L) reduction in the serum albumin concentration.

Calcium and phosphorus metabolism are closely linked. The primary hormonal regulators are PTH hormone, produced by the parathyroid glands, and calcitonin, produced by the thyroid C-cells. PTH increases calcium levels by increasing osteoclastic activity, while calcitonin does the opposite and inhibits osteoclasts. There are also many complex feedback loops, including those where calcium and activated vitamin D decrease PTH secretion, while elevated phosphorus levels increase PTH secretion. PTH and activated vitamin D also increase distal renal tubular reabsorption of calcium. PTH, FGF23, and Klotho (a regulatory protein that increases FGF23 activity) decrease serum phosphorus by inhibiting renal phosphorus absorption. Activated vitamin D increases phosphorus absorption from the intestine, renal tubules, and bones.

Disorders of calcium metabolism are encountered relatively frequently in routine clinical practice. Hypocalcemia is not seen as frequently as hypercalcemia is, but it can be potentially life-threatening if not appropriately recognized and promptly treated. Most hypocalcemia causes are acquired, but some are inherited. Clinical presentations can vary from asymptomatic to life-threatening arrhythmias or seizures.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Abhinav Goyal declares no relevant financial relationships with ineligible companies.

Disclosure: Catherine Anastasopoulou declares no relevant financial relationships with ineligible companies.

Disclosure: Michael Ngu declares no relevant financial relationships with ineligible companies.

Disclosure: Shikha Singh declares no relevant financial relationships with ineligible companies.

References

    1. Babić Leko M, Pleić N, Gunjača I, Zemunik T. Environmental Factors That Affect Parathyroid Hormone and Calcitonin Levels. Int J Mol Sci. 2021 Dec 21;23(1) - PMC - PubMed
    1. Pasieka JL, Wentworth K, Yeo CT, Cremers S, Dempster D, Fukumoto S, Goswami R, Houillier P, Levine MA, Pasternak JD, Perrier ND, Sitges-Serra A, Shoback DM. Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review. J Bone Miner Res. 2022 Dec;37(12):2586-2601. - PMC - PubMed
    1. Mannstadt M, Cianferotti L, Gafni RI, Giusti F, Kemp EH, Koch CA, Roszko KL, Yao L, Guyatt GH, Thakker RV, Xia W, Brandi ML. Hypoparathyroidism: Genetics and Diagnosis. J Bone Miner Res. 2022 Dec;37(12):2615-2629. - PubMed
    1. Del Rio P, Rossini M, Montana CM, Viani L, Pedrazzi G, Loderer T, Cozzani F. Postoperative hypocalcemia: analysis of factors influencing early hypocalcemia development following thyroid surgery. BMC Surg. 2019 Apr 24;18(Suppl 1):25. - PMC - PubMed
    1. Sastre A, Valentino K, Hannan FM, Lines KE, Gluck AK, Stevenson M, Ryalls M, Gorrigan RJ, Pullen D, Buck J, Sankaranarayanan S, Allgrove J, Thakker RV, Gevers EF. PTH Infusion for Seizures in Autosomal Dominant Hypocalcemia Type 1. N Engl J Med. 2021 Jul 08;385(2):189-191. - PMC - PubMed

Publication types

LinkOut - more resources